Morgan Stanley Nemaura Medical Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.15 - $0.34 $15 - $34	100 New	100 $0
Q2 2022 Oct 27, 2022	SELL	$2.53 - $4.42 $349 - $609	-138 Reduced 57.98%	100 $0
Q2 2022 Aug 15, 2022	SELL	$2.53 - $4.42 $349 - $609	-138 Reduced 57.98%	100 $0
Q1 2022 Oct 27, 2022	BUY	$3.78 - $4.66 $521 - $643	138 Added 138.0%	238 $1,000
Q1 2022 May 13, 2022	BUY	$3.78 - $4.66 $264 - $326	70 Added 41.67%	238 $1,000
Q4 2021 Feb 14, 2022	SELL	$4.12 - $6.35 $102,093 - $157,353	-24,780 Reduced 99.33%	168 $1,000
Q3 2021 Nov 15, 2021	BUY	$5.76 - $9.95 $143,700 - $248,232	24,948 New	24,948 $150,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.